Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-240
Closed -$12K 176
2015
Q4
$12K Buy
+240
New +$12.2K 0.01% 209
2014
Q3
Sell
-27,109
Closed -$1.81M 148
2014
Q2
$1.81M Buy
27,109
+757
+3% +$51.2K 0.94% 32
2014
Q1
$1.76M Buy
+26,352
New +$1.78M 0.93% 36

Other funds holding GSK

Kingfisher Capital's GSK Position: Q1 2016 in Review

Kingfisher Capital sold out of GSK (GSK) in Q1 2016, closing a stake of 240 shares — an estimated $12K sold.

Kingfisher Capital first reported a position in GSK in Q1 2014 and held it in 3 quarters. The position peaked at $1.81M in Q2 2014. 726 funds tracked by Wall St. Rank hold GSK as of Q1 2016.

  • Kingfisher Capital reported no remaining GSK position as of Q1 2016 after selling out during the quarter.
  • Kingfisher Capital sold 240 GSK shares in Q1 2016, an estimated $12K.
  • Kingfisher Capital first reported a position in GSK in Q1 2014 and held it in 3 quarters.
  • Kingfisher Capital's GSK position peaked at $1.81M in Q2 2014.
  • 726 funds tracked by Wall St. Rank held GSK as of Q1 2016.

Based on Kingfisher Capital's 13F filing for Q1 2016, filed 13 May 2016.